Date Filed | Type | Description |
08/14/2023 |
SC 13D/A
| Western Standard LLC reports a 13.9% stake in Merrimack Pharmaceuticals, Inc. |
08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/09/2023 |
4
| Andersen Eric (Director) has filed a Form 4 on MERRIMACK PHARMACEUTICALS INC
Txns:
| Bought 84,636 shares
@ $12.0037, valued at
$1M
Bought 49,857 shares
@ $12.0037, valued at
$598.5k
Bought 68,431 shares
@ $11.9959, valued at
$820.9k
Bought 18,626 shares
@ $11.9959, valued at
$223.4k
|
|
05/15/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
03/22/2023 |
4
| Andersen Eric (Director) has filed a Form 4 on MERRIMACK PHARMACEUTICALS INC
Txns:
| Bought 127,409 shares
@ $11.52, valued at
$1.5M
Bought 33,181 shares
@ $11.52, valued at
$382.2k
|
|
03/01/2023 |
4/A
| Andersen Eric (Director) has filed a Form 4 on MERRIMACK PHARMACEUTICALS INC
Txns:
| Bought 19,750 shares
@ $11.3576, valued at
$224.3k
Bought 4,985 shares
@ $11.3576, valued at
$56.6k
Bought 1,782 shares
@ $11.3998, valued at
$20.3k
Bought 450 shares
@ $11.3998, valued at
$5.1k
|
|
02/15/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/31/2023 |
4
| Andersen Eric (Director) has filed a Form 4 on MERRIMACK PHARMACEUTICALS INC
Txns:
| Bought 17,465 shares
@ $11.3965, valued at
$199k
Bought 4,410 shares
@ $11.3965, valued at
$50.3k
|
|
01/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/28/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/16/2022 |
13F-HR/A
| Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend] |
02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/15/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
09/20/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
08/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/03/2021 |
SC 13G
| Western Standard LLC reports a 6.7% stake in Marlin Business Services Corp. |
05/17/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
04/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/16/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/16/2020 |
4
| Andersen Eric (Director) has filed a Form 4 on MERRIMACK PHARMACEUTICALS INC
Txns:
| Bought 1,959 shares
@ $3.65, valued at
$7.2k
Bought 54,531 shares
@ $3.65, valued at
$199k
|
|
11/16/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/14/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/23/2020 |
SC 13D/A
| Western Standard LLC reports a 7.8% stake in Merrimack Pharmaceuticals, Inc. |
|